Latest Redmile Group, LLC Stock Portfolio
Redmile Group, LLC Performance:
2024 Q3: 7.01%YTD: -4.22%2023: -0.75%
Performance for 2024 Q3 is 7.01%, and YTD is -4.22%, and 2023 is -0.75%.
About Redmile Group, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Redmile Group, LLC reported an equity portfolio of $1.7 Billions as of 30 Sep, 2024.
The top stock holdings of Redmile Group, LLC are KRYS, NRIX, FOLD. The fund has invested 8.7% of it's portfolio in KRYSTAL BIOTECH INC and 5.7% of portfolio in NURIX THERAPEUTICS INC.
The fund managers got completely rid off BLUEPRINT MEDICINES CORP (BPMC), ENTRADA THERAPEUTICS INC (TRDA) and STANDARD BIOTOOLS INC (LAB) stocks. They significantly reduced their stock positions in INTUITIVE SURGICAL INC (ISRG), AMICUS THERAPEUTICS INC (FOLD) and KRYSTAL BIOTECH INC (KRYS). Redmile Group, LLC opened new stock positions in BIONTECH SE, ASTRIA THERAPEUTICS INC (ATXS) and PENUMBRA INC (PEN). The fund showed a lot of confidence in some stocks as they added substantially to ESTABLISHMENT LABS HLDGS INC (ESTA), 4D MOLECULAR THERAPEUTICS IN (FDMT) and REGENXBIO INC (RGNX).
The top stock holdings of Redmile Group, LLC are KRYS, NRIX, FOLD. The fund has invested 8.7% of it's portfolio in KRYSTAL BIOTECH INC and 5.7% of portfolio in NURIX THERAPEUTICS INC.
The fund managers got completely rid off BLUEPRINT MEDICINES CORP (BPMC), ENTRADA THERAPEUTICS INC (TRDA) and STANDARD BIOTOOLS INC (LAB) stocks. They significantly reduced their stock positions in INTUITIVE SURGICAL INC (ISRG), AMICUS THERAPEUTICS INC (FOLD) and KRYSTAL BIOTECH INC (KRYS). Redmile Group, LLC opened new stock positions in BIONTECH SE, ASTRIA THERAPEUTICS INC (ATXS) and PENUMBRA INC (PEN). The fund showed a lot of confidence in some stocks as they added substantially to ESTABLISHMENT LABS HLDGS INC (ESTA), 4D MOLECULAR THERAPEUTICS IN (FDMT) and REGENXBIO INC (RGNX).
Redmile Group, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Redmile Group, LLC made a return of 7.01% in the last quarter. In trailing 12 months, it's portfolio return was 5.96%.
New Buys
| Ticker | $ Bought |
|---|---|
| biontech se | 18,344,700 |
| oruka therapeutics inc | 10,091,500 |
| astria therapeutics inc | 3,422,830 |
| penumbra inc | 2,690,610 |
| hookipa pharma inc | 457,417 |
New stocks bought by Redmile Group, LLC
Additions
| Ticker | % Inc. |
|---|---|
| establishment labs hldgs inc | 22.9 |
| 4d molecular therapeutics in | 17.57 |
| regenxbio inc | 7.07 |
| adc therapeutics sa | 2.62 |
Additions to existing portfolio by Redmile Group, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| intuitive surgical inc | -32.99 |
| amicus therapeutics inc | -22.17 |
| krystal biotech inc | -20.65 |
| stryker corporation | -17.08 |
| boston scientific corp | -15.22 |
| akero therapeutics inc | -14.06 |
| replimune group inc | -14.04 |
| cytokinetics inc | -13.19 |
Redmile Group, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| entrada therapeutics inc | -7,993,840 |
| standard biotools inc | -728,587 |
| alpha teknova inc | -211,677 |
| hookipa pharma inc | -629,538 |
| blueprint medicines corp | -10,175,000 |
Redmile Group, LLC got rid off the above stocks
Sector Distribution
Redmile Group, LLC has about 85.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 85.5 |
| Others | 14.3 |
Market Cap. Distribution
Redmile Group, LLC has about 5.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| SMALL-CAP | 45.1 |
| MID-CAP | 26.9 |
| UNALLOCATED | 17.2 |
| MICRO-CAP | 5.4 |
| LARGE-CAP | 5.2 |
Stocks belong to which Index?
About 75.4% of the stocks held by Redmile Group, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 70.2 |
| Others | 24.6 |
| S&P 500 | 5.2 |
Redmile Group, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Redmile Group, LLC
Redmile Group, LLC has 63 stocks in it's portfolio. About 44% of the portfolio is in top 10 stocks. ALXO proved to be the most loss making stock for the portfolio. IGMS was the most profitable stock for Redmile Group, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABSI | absci corporation | 1.86 | 8,253,320 | 31,527,700 | unchanged | 0.00 | ||
| ACHL | achilles therapeutics plc | 0.10 | 1,608,090 | 1,640,250 | unchanged | 0.00 | ||
| ADAP | adaptimmune therapeutics plc | 0.04 | 715,607 | 680,113 | unchanged | 0.00 | ||
| ADCT | adc therapeutics sa | 2.91 | 15,669,200 | 49,358,000 | added | 2.62 | ||
| ADGI | invivyd inc | 0.18 | 3,065,710 | 3,127,030 | unchanged | 0.00 | ||
| AKRO | akero therapeutics inc | 2.35 | 1,387,480 | 39,806,800 | reduced | -14.06 | ||
| ALLK | allakos inc | 0.12 | 3,077,830 | 2,010,440 | unchanged | 0.00 | ||
| ALVR | allovir inc | 0.09 | 1,907,970 | 1,542,590 | unchanged | 0.00 | ||
| ALXO | alx oncology hldgs inc | 0.41 | 3,836,580 | 6,982,570 | reduced | -4.95 | ||
| ANNX | annexon inc | 2.24 | 6,427,460 | 38,050,600 | unchanged | 0.00 | ||
| ARDX | ardelyx inc | 0.67 | 1,660,760 | 11,442,700 | reduced | -11.73 | ||
| ATRA | atara biotherapeutics inc | 0.22 | 452,270 | 3,676,960 | unchanged | 0.00 | ||
| ATXS | astria therapeutics inc | 0.20 | 310,884 | 3,422,830 | new | |||
| AUGX | augmedix inc | 2.27 | 16,380,300 | 38,493,800 | unchanged | 0.00 | ||
| BEAM | beam therapeutics inc | 2.33 | 1,611,010 | 39,469,800 | reduced | -5.4 | ||
| BPMC | blueprint medicines corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BSX | boston scientific corp | 1.63 | 330,873 | 27,727,200 | reduced | -15.22 | ||
| CABA | cabaletta bio inc | 0.12 | 442,826 | 2,090,140 | unchanged | 0.00 | ||
| CLDX | celldex therapeutics inc new | 1.32 | 657,175 | 22,337,400 | reduced | -8.56 | ||
| COGT | cogent biosciences inc | 2.85 | 4,484,380 | 48,431,300 | reduced | -6.57 | ||